A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Pediatric Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
Clinical trial NCT04958265 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04958265
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-17
- Primary completion
- 2025-07-04
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.